Acetylcholinesterase inhibitors play a symptomatic therapeutic role in a variety of ways, including the inhibition of AChE and the protection of cells from β-amyloid-induced damage and free radical toxicity.[70] For example, in a study exploring and validating the mechanism of donepezil in Alzheimer’s disease, network pharmacology and molecular docking techniques were also employed. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.